Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

2,3,4,5-Tetramethoxyphenethylamine

From Wikipedia, the free encyclopedia
(Redirected from TeMPEA-1)

TeMPEA
Clinical data
Other namesTeMPEA; TeMPEA-1; 2,3,4,5-TeMPEA; 2-Methoxymescaline; Methoxymescaline; 2-Methoxy-TMPEA; 3-Methoxy-2C-O; 3-Methoxy-TMPEA-2
ATC code
  • None
Identifiers
  • 2-(2,3,4,5-tetramethoxyphenyl)ethanamine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H19NO4
Molar mass241.287 g·mol−1
3D model (JSmol)
  • COC1=C(C(=C(C(=C1)CCN)OC)OC)OC
  • InChI=1S/C12H19NO4/c1-14-9-7-8(5-6-13)10(15-2)12(17-4)11(9)16-3/h7H,5-6,13H2,1-4H3
  • Key:GJKJPCJLMHZZFK-UHFFFAOYSA-N

2,3,4,5-Tetramethoxyphenethylamine (TeMPEA or 2,3,4,5-TeMPEA), also known as 2-methoxymescaline, is a drug of the phenethylamine family related to mescaline (3,4,5-trimethoxyphenethylamine) and the 2C drugs (4-substituted 2,5-dimethoxyphenethylamines).[1][2] It was reported to be twice as potent as mescaline in producing behavioral changes in animals.[2][3] However, it does not seem to have been tested in humans.[1][2] The drug was not described in Alexander Shulgin's PiHKAL, though it was included in The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4] A derivative is 2,3,4,5-tetramethoxyamphetamine (TeMA), which was included in PiHKAL, and was reported to be inactive in humans at the tested doses.[5]

See also

[edit]

References

[edit]
  1. 1 2 3 Shulgin A, Manning T, Daley PF (2011). "#114. TeMPEA". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 280–281. ISBN 978-0-9630096-3-0. OCLC 709667010.
  2. 1 2 3 Brimblecombe RW, Pinder RM (1975). "Phenylalkylamines and Their Derivatives". Hallucinogenic Agents. Bristol: Wright-Scientechnica. pp. 55–97.
  3. Smythies JR, Bradley RJ, Johnston VS, Benington F, Morin RD, Clark LC (1967). "Structure-activity relationship studies on mescaline. 3. The influence of the methoxy groups". Psychopharmacologia. 10 (5): 379–387. doi:10.1007/BF00403978. PMID 5588333.
  4. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  5. Shulgin AT, Shulgin A (1991). PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. ISBN 978-0-9630096-0-9. OCLC 25627628.
[edit]